| Investigation of chalcones and benzochalcones as inhibitors of breast cancer resistance protein K Juvale, VFS Pape, M Wiese Bioorganic & medicinal chemistry 20 (1), 346-355, 2012 | 144 | 2012 |
| Synthesis and biological evaluation of flavones and benzoflavones as inhibitors of BCRP/ABCG2 K Juvale, K Stefan, M Wiese European journal of medicinal chemistry 67, 115-126, 2013 | 110 | 2013 |
| Investigation of quinazolines as inhibitors of breast cancer resistance protein (ABCG2) K Juvale, J Gallus, M Wiese Bioorganic & medicinal chemistry 21 (24), 7858-7873, 2013 | 108 | 2013 |
| Monocarboxylate transporter 1 and 4 inhibitors as potential therapeutics for treating solid tumours: A review with structure-activity relationship insights S Puri, K Juvale European journal of medicinal chemistry 199, 112393, 2020 | 83 | 2020 |
| The combination of quinazoline and chalcone moieties leads to novel potent heterodimeric modulators of breast cancer resistance protein (BCRP/ABCG2) S Kraege, K Stefan, K Juvale, T Ross, T Willmes, M Wiese European Journal of Medicinal Chemistry 117, 212-229, 2016 | 70 | 2016 |
| 4-Substituted-2-phenylquinazolines as inhibitors of BCRP K Juvale, M Wiese Bioorganic & medicinal chemistry letters 22 (21), 6766-6769, 2012 | 69 | 2012 |
| Novel chalcone and flavone derivatives as selective and dual inhibitors of the transport proteins ABCB1 and ABCG2 K Silbermann, CP Shah, NU Sahu, K Juvale, SM Stefan, PS Kharkar, ... European Journal of Medicinal Chemistry 164, 193-213, 2019 | 45 | 2019 |
| Characterization of 3-methoxy flavones for their interaction with ABCG2 as suggested by ATPase activity J Gallus, K Juvale, M Wiese Biochimica et Biophysica Acta (BBA) - Biomembranes 1838 (11), 2929–2938, 2014 | 38 | 2014 |
| Evaluation of oxindole derivatives as a potential anticancer agent against breast carcinoma cells: In vitro, in silico, and molecular docking study S Puri, I Ahmad, H Patel, K Kumar, K Juvale Toxicology in Vitro 86, 105517, 2023 | 30 | 2023 |
| Cancer cell fusion: A potential target to tackle drug-resistant and metastatic cancer cells C Fernandes, P Prabhu, K Juvale, D Suares, YC Mayur Drug Discovery Today 24 (9), 1836-1844, 2019 | 26 | 2019 |
| Inhibitors of inosine 5′-monophosphate dehydrogenase as emerging new generation antimicrobial agents K Juvale, A Shaik, S Kirubakaran Medchemcomm 10 (8), 1290-1301, 2019 | 26 | 2019 |
| Evaluation of dual P-gp-BCRP inhibitors as nanoparticle formulation MS Singh, K Juvale, M Wiese, A Lamprecht European Journal of Pharmaceutical Sciences 77, 1-8, 2015 | 24 | 2015 |
| Indole derivatives as new structural class of potent and antiproliferative inhibitors of monocarboxylate transporter 1 (MCT1; SLC16A1) S Puri, K Stefan, SL Khan, J Pahnke, SM Stefan, K Juvale Journal of Medicinal Chemistry 66 (1), 657-676, 2022 | 22 | 2022 |
| Synthesis and evaluation of phenytoin derivatives as anticonvulsant agents M Deodhar, P Sable, A Bhosale, K Juvale, R Dumbare, P Sakpal Turkish Journal of Chemistry 33 (3), 367-373, 2009 | 17 | 2009 |
| Design of inhibitors of BCRP/ABCG2 K Juvale, M Wiese Future Medicinal Chemistry 7 (12), 1521-1527, 2015 | 16 | 2015 |
| Identification of selective inhibitors of Helicobacter pylori IMPDH as a targeted therapy for the infection K Juvale, G Purushothaman, V Singh, A Shaik, S Ravi, V Thiruvenkatam, ... Scientific Reports 9 (1), 190, 2019 | 14 | 2019 |
| A comprehensive review on the indazole based derivatives as targeted anticancer agents S Puri, S Sawant, K Juvale Journal of Molecular Structure 1284, 135327, 2023 | 12 | 2023 |
| Formulation and optimization of gefitinib-loaded nanosuspension prepared using a newly developed dendritic lipopeptide oligomer material N Hegde, K Juvale, B Prabhakar Chemical Papers, 1-16, 2021 | 9 | 2021 |
| Long circulating polymeric nanoparticles of gemcitabine HCl using PLGA-PEG-PPG-PEG block co-polymer K Kale, A Fulfager, K Juvale, KS Yadav International Journal of Polymeric Materials and Polymeric Biomaterials 73 …, 2024 | 8 | 2024 |
| Synthesis and in vitro enzymatic studies of new 3-aryldiazenyl indoles as promising Helicobacter pylori IMPDH inhibitors S Jangra, G Purushothaman, K Juvale, S Ravi, A Menon, ... Current Topics in Medicinal Chemistry 19 (5), 376-382, 2019 | 8 | 2019 |
Sivapriya KirubakaranProfessorDirección de correo verificada de iitgn.ac.in
